Found 1 match for your search
February 3, 2022
IPIC Calls on Industry Canada to Clarify Agent-Client Privilege Legislation
A decision of a Prothonotary of the Federal Court in JANSSEN Inc. and MITSUBISHI TANABE PHARMA Corporation v. SANDOZ CANADA Inc. (2021 FC 1265) in November of 2021 included an interpretation of the 2016 amendments to the Patent Act which granted privilege to communications between a patent agent and their client (Section 16.1 of the Patent Act).